Lucas Capital Management’s Novartis NVS Stock Holding History

Lucas Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,790	Closed	-$203K	–	97
2018 Q1	$203K	Sell	2,790 -223	-7%	-$17K	0.2%	92
2017 Q4	$227K	Hold	3,013	–	–	0.2%	96
2017 Q3	$232K	Buy	+3,013	New	+$228K	0.21%	93
2015 Q4	–	Sell	-2,455	Closed	-$202K	–	127
2015 Q3	$202K	Hold	2,455	–	–	0.12%	112
2015 Q2	$216K	Hold	2,455	–	–	0.1%	124
2015 Q1	$217K	Sell	2,455 -112	-4%	-$9.93K	0.09%	120
2014 Q4	$213K	Hold	2,567	–	–	0.08%	124
2014 Q3	$216K	Hold	2,567	–	–	0.07%	135
2014 Q2	$208K	Buy	+2,567	New	+$202K	0.07%	140

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Lucas Capital Management's NVS Position: Q2 2018 in Review

Lucas Capital Management sold out of Novartis (NVS) in Q2 2018, closing a stake of 2,790 shares — an estimated $203K sold.

Lucas Capital Management first reported a position in NVS in Q2 2014 and held it in 9 quarters. The position peaked at $232K in Q3 2017. 987 funds tracked by Wall St. Rank hold NVS as of Q2 2018.

Lucas Capital Management reported no remaining Novartis position as of Q2 2018 after selling out during the quarter.
Lucas Capital Management sold 2,790 Novartis shares in Q2 2018, an estimated $203K.
Lucas Capital Management first reported a position in Novartis in Q2 2014 and held it in 9 quarters.
Lucas Capital Management's Novartis position peaked at $232K in Q3 2017.
987 funds tracked by Wall St. Rank held Novartis as of Q2 2018.

Based on Lucas Capital Management's 13F filing for Q2 2018, filed 11 Jul 2018.